Please select the market sector you are interested in.
Please select the university you are interested in.
Show only Easy Access opportunities.
Narrow your search with a few keywords.
Sign up to our technology alerts and be the first to hear about any new technology opportunities from Scotland's universities
Certain types of university intellectual property can sometimes prove difficult to commercialise through traditional routes, usually because it is at an early stage of development, or because it presents enough uncertainty for companies to risk an investment.
University Technology’s Easy Access portal offers access to this type of intellectual property at no cost, to enable companies to evaluate it and put it to use quickly, with reduced risk.
Easy Access uses quick and simple licence agreements to fast-track the transfer of knowledge and expertise from Scotland’s universities to industry, so that these technologies may be developed for the benefit of the economy and society.
Through this initiative, our aim is to make it easier for Scottish universities and industry to work together and build strong, long-term relationships with industry partners.
Showing 21 - 30 of 87 opportunities
Adherent glioma neural stem (GNS) cell lines that retain the characteristics of the original tumour-initiating cells, delivering a powerful model system for chemical and genetic screening.
This irrigating solution with superior chondro-protective properties reduces damage to cartilage cells (chondrocytes) during orthopaedic procedures. This helps preserve a healthy cartilage and lowers the risk of developing degenerative joint diseases, like osteoarthritis.
Aberdeen researchers have developed a novel antibody that demonstrates clear activity against C. albicans in vitro in an immune system-independent manner.
Researchers at Aberdeen have developed a novel vaccination technology. Initially developed as a method of vaccinating fish without the need for injection, thus avoiding stress and infection risks. Testing to date has been carried out in fish, however the technology is believed to be potentially app...
Researchers at the University of Aberdeen have shown that the myeloid inhibitory C-type lectin like receptor has a previously unexpected role in rheumatoid arthritis. This provides a novel mechanism for therapeutic approaches and for diagnosis and prognosis of rheumatoid arthritis.
This diagnostic test uses next generation sequencing techniques to predict which rheumatoid arthritis patients will not respond to disease modifying anti-rheumatic drugs (DMARDs), and who should receive biologic treatment at diagnosis.
Researchers at the University of Dundee have uncovered fundamental insights into a signalling pathway central to the loss of neurons in Parkinson’s Disease. This insight provides important biomarkers for the disease, which could help with early diagnosis and patient stratification.
The nature of bladder physiology means it is challenging to treat bladder conditions systemically as only low concentrations of drug are able to get through to the target site. Strathclyde is developing silk-based drug delivery systems for intravesical administration and hopes to achieve sustained d...
Researchers at the University of Dundee have developed a novel sinus drainage system which can be accurately inserted into all paranasal sinus regions, for effective irrigation post-surgery.
Researchers at the University of Dundee have discovered that agents including certain aminoglycoside antibiotics have the potential to be used as effective treatment for Ichthyosis Vulgaris and other skin disorders.